SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
71.10
-0.10 (-0.14%)
Feb 11, 2026, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
SYN-TECH Chem. & Pharm. had revenue of 336.71M TWD in the quarter ending September 30, 2025, with 1.85% growth. This brings the company's revenue in the last twelve months to 1.29B, up 6.28% year-over-year. In the year 2024, SYN-TECH Chem. & Pharm. had annual revenue of 1.26B with 12.83% growth.
Revenue (ttm)
1.29B
Revenue Growth
+6.28%
P/S Ratio
2.46
Revenue / Employee
5.69M
Employees
227
Market Cap
3.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
| Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
| Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
| Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
| Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.13B |
| Apex Biotechnology | 1.96B |
| Genovate Biotechnology | 491.23M |
| Sagittarius Life Science | 424.44M |
| 3D Global Biotech | 324.87M |
| G&E Herbal Biotechnology | 311.78M |
| HeXun Biosciences | 290.83M |
| Intech Biopharm | 113.85M |